HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of the treatment of herpes genitalis in men with proflavine photoinactivation, idoxuridine ointment, and normal saline.

Abstract
36 male patients with genital infection by HSV confirmed by culture were each allocated to one of three treatment groups: (1) Proflavine photoinactivation, (2) 0.5 per cent. idoxuridine ointment (IDU), (3) Normal saline. They were assessed objectively at each attendance by measurement of the lesions with an operating microscope fitted with a measuring grid in one eyepiece. Material for culture for HSV was taken at each visit; the presence of symptoms (pain, discomfort, and irritation) was noted. The areas of lesions in the proflavine photoinactivation group remained larger significantly longer than in the other groups, the healing time was slower, and HSV could be isolated for longer. It is concluded that proflavine photoinactivation is of no greater value than 0.5 per cent. IDU or normal saline in the treatment of genital infection by HSV in the male.
AuthorsP K Taylor, N R Doherty
JournalThe British journal of venereal diseases (Br J Vener Dis) Vol. 51 Issue 2 Pg. 125-9 (Apr 1975) ISSN: 0007-134X [Print] England
PMID1093634 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Acridines
  • Ointments
  • Sodium Chloride
  • Proflavine
  • Idoxuridine
Topics
  • Acridines (therapeutic use)
  • Clinical Trials as Topic
  • Complement Fixation Tests
  • Evaluation Studies as Topic
  • Genital Diseases, Male (drug therapy, therapy)
  • Herpes Simplex (drug therapy, therapy)
  • Humans
  • Idoxuridine (therapeutic use)
  • Male
  • Ointments
  • Phototherapy
  • Proflavine (therapeutic use)
  • Recurrence
  • Sodium Chloride (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: